United Therapeutics | UTHR - Eps Gewinn Pro Aktie

Aktienkurs
564.94
Täglich Wechseln
-4.24 -0.74%
Monatlich
-1.71%
Jährlich
87.43%
Q2 Prognose
553.25

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 5.82 6.94 6.63 May/06
FY2025Q4 Dec/2025 7.70 7.07 6.19 Feb/25
FY2025Q3 Sep/2025 7.16 7.43 6.39 Oct/29
FY2025Q2 Jun/2025 6.41 7.35 5.85 Jul/30
FY2025Q1 Mar/2025 6.63 6.53 6.17 Apr/30




Eps Veränderung Datum
Amarin USD 0.14 0.06 2025-12
Ardelyx USD -0.15 0.15 2026-03
Baxter International USD 0.36 0.08 2026-03
Bayer EUR 0.62 0.05 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Emergent BioSolutions USD -0.77 0.29 2023-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Gilead Sciences USD 2.03 0.17 2026-03
GlaxoSmithKline GBP 0.43 0.17 2026-03
Halozyme Therapeutics USD -0.24 1.96 2025-12
Insmed USD -0.76 0.78 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
J&J USD 2.7 0.24 2026-03
Lexicon Pharmaceuticals USD -0.04 0.01 2025-12
Moderna USD -3.4 1.29 2026-03
Omeros USD -1.12 0.37 2024-06
Pfizer USD 0.75 0.09 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Sangamo BioSciences USD -0.18 0.1 2024-06
Sarepta Therapeutics USD 3.16 6.74 2026-03
Teva Pharmaceutical Industries USD 1.57 1.41 2026-03
United Therapeutics USD 5.82 1.88 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03